1. Пульмонология. Национальное руководство. Краткое издание. Под ред. А.Г. Чучалина. М.: ГЭОТАР-Медиа, 2013 [Pul'monologiia. Natsional'noe rukovodstvo. Kratkoe izdanie. Pod red. A.G. Chuchalina. Moscow: GEOTAR-Media, 2013 (in Russian)].
2. Bartlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis. 2000;31(2):347-82. DOI:10.1086/313954
3. Wenzel RP, Fowler AA. Acute Bronchitis. N Engl J Med. 2006;355(20):2125-10. DOI:10.1056/nejmcp061493
4. Albert RH. Diagnosis and treatment of acute bronchitis. Am Fam Physician. 2010;82(11):1345-50.
5. Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections – full version. Clin Microbiol Infect. 2011;(17 Suppl. 6):E1-59. DOI:10.1111/j.1469-0691.2011.03672.x
6. Зайцев А.А., Кулагина И.Ц. Острый бронхит. Фарматека. 2015;14(307):89-95 [Zaitsev AA, Kulagina ITs. Acute bronchitis. Pharmacate. 2015;14(307):89-95 (in Russian)].
7. Falsey AR, Criddle MM, Kolassa JE, et al. Evaluation of a handwashing intervention to reduce respiratory illness rates in senior day-care centers. Infect Control Hosp Epidemiol. 1999;20(3):200-2. DOI:10.1086/501612
8. Wark P. Bronchitis (acute). BMJ Clin Evid. 2015;2015:1508.
9. Macfarlane J, Holmes W, Gard P, et al. Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community. Thorax. 2001;56(2):109-14. DOI:10.1136/thorax.56.2.109
10. Smucny J, Fahey T, Becker L, Glazier R. Antibiotics for acute bronchitis. Cochrane Database Syst Rev. 2004;(4):CD000245. DOI:10.1002/14651858.CD000245.pub2
11. Gonzales R, Bartlett JG, Besser RE, et al. Principles of Appropriate Antibiotic Use for Treatment of Uncomplicated Acute Bronchitis: Background. Ann Intern Med. 2013;134(6):521-2. DOI:10.7326/0003-4819-134-6-200103200-00021
12. Irwin RS, Baumann MH, Bolser DC, et al. Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1 Suppl.):1S-23S. DOI:10.1378/chest.129.1_suppl.1S
13. Tackett KL, Atkins A. Evidence-based acute bronchitis therapy. J Pharm Pract. 2012;25(6):586-90. DOI:10.1177/0897190012460826
14. Зайцев А.А. Направления фармакотерапии и профилактики острых респираторных вирусных инфекций. РМЖ. 2009;17(23):1525-9 [Zaitsev AA. Napravleniia farmakoterapii i profilaktiki ostrykh respiratornykh virusnykh infektsii. RMZh. 2009;17(23):1525-9 (in Russian)].
15. Ott SR, Rohde G, Lepper PM, et al. The impact of viruses in lower respiratory tract infections of the adult. Part II: acute bronchitis, acute exacerbated COPD, pneumonia, and influenza. Pneumologie. 2010;64(1):18-27 (in German). DOI:10.1055/s-0029-1215197
16. Зайцев А.А., Казаков С.П., Филон Е.А., и др. Этиология и эффективная фармакотерапия острого бронхита. Лечащий врач. 2025;28(1):32-7 [Zaitsev AA, Kazakov SP, Filon EA, et al. Etiologiia i effektivnaia farmakoterapiia ostrogo bronkhita. Lechashchii vrach. 2025;28(1):32-7 (in Russian)].
17. Зайцев А.А., Будорагин И.Е., Исаева Е.И., и др. Острый бронхит: расставляем приоритеты. Антибиотики и химиотерапия. 2019;64:17-22 [Zaitsev AA, Budoragin IE, Isaeva EI, et al. Ostryi bronkhit: rasstavliaem prioritety. Antibiotiki i khimioterapiia. 2019;64:17-22 (in Russian)].
18. Зайцев А.А., Филон Е.А., Сторожева Ю.И. Острый бронхит – современные возможности мукоактивной терапии. Терапевтический архив. 2023;95(11):943-50 [Zaitsev AA, Filon EA, Storozheva YI. Acute bronchitis – modern possibilities of mucactive therapy. Terapevticheskii Arkhiv (Ter. Arkh.). 2023;95(11):943-50 (in Russian)]. DOI:10.26442/00403660.2023.11.202470
19. Hart AM. Evidence-based diagnosis and management of acute bronchitis. Nurse Pract. 2014;39(9):32-9. DOI:10.1097/01.NPR.0000452978.99676.2b
20. Лещенко И.В., Зайцев А.А., Эсаулова Н.А., Малявин А.Г. Острый бронхит. Основные акценты. Терапия. 2023;7:194-200 [Leshchenko IV, Zaitsev AA, Esaulova NA, Maliavin AG. Ostryi bronkhit. Osnovnye aktsenty. Terapiia. 2023;7:194-200 (in Russian)].
21. Creer DD, Dilworth JP, Gillespie SH, et al. Aetiological role of viral and bacterial infections in acute adult lower respiratory tract infection (LRTI) in primary care. Thorax. 2006;61(1):75-9. DOI:10.1136/thx.2004.027441
22. Wadowsky RM, Castilla EA, Laus S, et al. Evaluation of Chlamydia pneumoniae and Mycoplasma pneumoniae as etiologic agents of persistent cough in adolescents and adults. J Clin Microbiol. 2002;40(2):637-40. DOI:10.1128/JCM.40.2.637-640.2002
23. Riffelmann M, Littmann M, Hülße C, et al. Pertussis bei Erwachsenen: Häufigkeit, Symptome und Kosten. Dtsch med Wochenschr. 2006;131(50):2829-84. DOI:10.1055/s-2006-957208
24. Лещенко И.В. Острый бронхит. М.: ГЭОТАР-Медиа, 2019 [Leshchenko IV. Ostryi bronkhit. Moscow: GEOTAR-Media, 2019 (in Russian)].
25. Зайцев А.А., Мирошниченко Н.А., Овчинников А.Ю., Николаева Ю.О. Острые респираторные вирусные инфекции: консенсус о рациональной терапии. Consilium Medicum. 2024;26(9):575-7 [Zaytsev AA, Miroshnichenko NA, Ovchinnikov AY, Nikolaeva YO. Acute respiratory viral infections: Consensus on rational therapy. Consilium Medicum. 2024;26(9):575-7 (in Russian)]. DOI:10.26442/20751753.2024.9.202956
26. Knutson D, Braun C. Diagnosis and management of acute bronchitis. Am Fam Physician. 2002;65(10):2039-44.
27. Meza RA, Bridges-Webb C, Sayer GP, et al. The management of acute bronchitis in general practice: results from the Australian Morbidity and Treatment Survey, 1990–1991. Aust Fam Physician. 1994;23(8):1550-3.
28. Nennig ME, Shinefield HR, Edwards KM, et al. Prevalence and incidence of adult pertussis in an urban population. JAMA. 1996;275(21):1672-4.
29. Зайцев А.А., Овчинников Ю.В., Кондратьева Т.В. Биологические маркеры воспаления при внебольничной пневмонии. Consilium Medicum. 2014;11:36-41 [Zaitsev AA, Ovchinnikov IuV, Kondrat'eva TV. Biologicheskie markery vospaleniia pri vnebol'nichnoi pnevmonii. Consilium Medicum. 2014;11:36-41 (in Russian)].
30. Franck AJ, Smith RE. Antibiotic use for acute upper respiratory tract infections in a veteran population. J Am Pharm Assoc (2003). 2010;50(6):726-9. DOI:10.1331/JAPhA.2010.09103
31. Зайцев А.А., Кулагина И.Ц. Фармакотерапия острого бронхита. Consilium Medicum. 2012;11(14):16-21 [Zaitsev AA, Kulagina ITs. Farmakoterapiia ostrogo bronkhita. Consilium Medicum. 2012;11(14):16-21 (in Russian)].
32. Llor C, Moragas A, Bayona C, et al. Effectiveness of anti-inflammatory treatment versus antibiotic therapy and placebo for patients with non-complicated acute bronchitis with purulent sputum. The BAAP Study protocol. BMC Pulm Med. 2011;11:38. DOI:10.1186/1471-2466-11-38
33. Smith SM, Fahey T, Smucny J, Becker LA. Antibiotics for acute bronchitis. Cochrane Database Syst Rev. 2017;6(6):CD000245. DOI:10.1002/14651858.CD000245.pub4
34. Mainous AG 3rd, Saxena S, Hueston WJ, et al. Ambulatory antibiotic prescribing for acute bronchitis and cough and hospital admissions for respiratory infections: time trends analysis. J R Soc Med. 2006;99(7):358-62. DOI:10.1177/014107680609900719
35. Стратегия и тактика рационального применения антимикробных средств в амбулаторной практике: евразийские клинические рекомендации. М.: МедКом-Про, 2022 [Strategiia i taktika ratsional'nogo primeneniia antimikrobnykh sredstv v ambulatornoi praktike: evraziiskie klinicheskie rekomendatsii. Moscow: MedKom-Pro, 2022 (in Russian)].
36. Respiratory tract infections (self-limiting): prescribing antibiotics. Available at: http://www.nice.org.uk/CG069. Accessed: 09.04.2025.
37. Altiner A, Wilm S, Däubener W, et al. Sputum colour for diagnosis of a bacterial infection in patients with acute cough. Scand J Prim Health Care. 2009;27(2):70-3. DOI:10.1080/02813430902759663
38. Laopaiboon M, Panpanich R, Swa Mya K. Azithromycin for acute lower respiratory tract infections. Cochrane Database Syst Rev. 2015;2015(3):CD001954. DOI:10.1002/14651858.CD001954.pub4
39. Профилактика, диагностика и лечение новой коронавирусной инфекции COVID-19. Временные методические рекомендации. Версия 18. 26.10.2023 [Profilaktika, diagnostika i lechenie novoi koronavirusnoi infektsii COVID-19. Vremennye metodicheskie rekomendatsii. Versiia 18. 26.10.2023 (in Russian)].
40. Smucny J, Flynn C, Becker L, Glazier R. Beta2-agonists for acute bronchitis. Cochrane Database Syst Rev. 2004;(1):CD001726. DOI:10.1002/14651858.CD001726.pub2
41. El-Gohary M, Hay AD, Coventry P, et al. Corticosteroids for acute and subacute cough following respiratory tract infection: a systematic review. Fam Pract. 2013;30(5):492-500. DOI:10.1093/fampra/cmt034
42. Зайцев А.А., Оковитый С.В., Крюков Е.В. Кашель. Практическое пособие для врачей. М. 2015 [Zaitsev AA, Okovityi SV, Kriukov EV. Kashel'. Prakticheskoe posobie dlia vrachei. Moscow. 2015 (in Russian)].
43. Купаев В.И. Оценка эффективности терапии острого бронхита комбинацией муколитика/b2-агониста по сравнению с монотерапией муколитиком в реальной общей врачебной практике. Доктор.ру. 2017;5:16-18 [Kupaev VI. Otsenka effektivnosti terapii ostrogo bronkhita kombinatsiei mukolitika/b2-agonista po sravneniiu s monoterapiei mukolitikom v real'noi obshchei vrachebnoi praktike. Doktor.ru. 2017;5:16-18 (in Russian)].
44. Prabhu Shankar S, Chandrashekharan S, Bolmall CS, Baliga V. Efficacy, safety and tolerability of salbutamol + guaiphenesin + bromhexine (Ascoril) expectorant versus expectorants containing salbutamol and either guaiphenesin or bromhexine in productive cough: a randomised controlled comparative study. J Indian Med Assoc. 2010;108(5):313-4, 316-8, 320.
45. Kemmerich B. Evaluation of efficacy and tolerability of a fixed combination of dry extracts of thyme herb and primrose root in adults suffering from acute bronchitis with productive cough. A prospective, double-blind, placebo-controlled multicentre clinical trial. Arzneimittelforschung. 2007;57(9):607-15. DOI:10.1055/s-0031-1296656
46. Kemmerich B, Eberhardt R, Stammer H. Efficacy and tolerability of a fluid extract combination of thyme herb and ivy leaves and matched placebo in adults suffering from acute bronchitis with productive cough. A prospective, double-blind, placebo-controlled clinical trial. Arzneimittelforschung. 2006;56(9):652-60. DOI:10.1055/s-0031-1296767
47. Зайцев А.А., Лещенко И.В., Эсаулова Н.А., Викторова И.А. Оценка эффективности и безопасности комбинированного препарата, содержащего амброксол, гвайфенезин и левосальбутамол, в сравнении с фиксированной комбинацией бромгексин/гвайфенезин/сальбутамол в терапии продуктивного кашля у взрослых пациентов с острым бронхитом. Терапевтический архив. 2023;95(3):236-42 [Zaitsev  AA, Leshchenko IV, Esaulova NA, Viktorova IA. Evaluation of the efficacy and safety of a combination drug containing ambroxol, guaifenesin, and levosalbutamol versus a fixed-dose combination of bromhexine/guaifenesin/salbutamol in the treatment of productive cough in adult patients with acute bronchitis. Terapevticheskii Arkhiv (Ter. Arkh.). 2023;95(3):236-42 (in Russian)]. DOI:10.17116/profmed202326061108
48. Лещенко И.В., Эсаулова Н.А. Комбинированная терапия продуктивного кашля при острой респираторной вирусной инфекции (ОРВИ) и остром бронхите в реальной клинической практике. Терапевтический архив. 2024;96(1):46-52 [Leshchenko IV, Esaulova NA. Combination therapy for productive cough in acute respiratory viral infection (ARVI) and acute bronchitis in real clinical practice. Terapevticheskii Arkhiv (Ter. Arkh.). 2024;96(1):46-52 (in Russian)]. DOI:10.26442/00403660.2024.01.202584
49. Зайцев А.А., Куликова Н.А., Филон Е.А., и др. Клиническая эффективность мукоактивной терапии 7%-м гипертоническим раствором у пациентов с острым бронхитом. Медицинский Совет. 2023;(23):136-41 [Zaitsev AA, Kulikova NA, Filon EA, et al. Clinical efficacy of mucoactive therapy with 7% hypertonic saline in patients with acute bronchitis. Meditsinskiy sovet = Medical Council. 2023;(23):136-41 (in Russian)]. DOI:10.21518/2079-701x-2022-16-23-136-141
50. Виброакустическая терапия. Клинический протокол. Режим доступа: https://amu.edu.kz/ru/personal/Clinical-work/clinic/Clinical-protocols. Ссылка активна на 09.04.2025 [Vibroakusticheskaia terapiia. Klinicheskii protokol. Available at: https://amu.edu.kz/ru/personal/Clinical-work/clinic/Clinical-protocols. Accessed: 09.04.2025 (in Russian)].
51. Об утверждении национального календаря профилактических прививок, календаря профилактических прививок по эпидемическим показаниям и порядка проведения профилактических прививок: приказ Минздрава России: [от 6 декабря 2021 г. №1122н; зарег. в Минюсте России 20 декабря 2021 г. №66435]. Режим доступа: https://normativ.kontur.ru/document?moduleId=1&documentId=475217&ysclid=mang9jrahl951597019. Ссылка активна на 09.04.2025 [Ob utverzhdenii natsional'nogo kalendaria profilakticheskikh privivok, kalendaria profilakticheskikh privivok po epidemicheskim pokazaniiam i poriadka provedeniia profilakticheskikh privivok: prikaz Minzdrava Rossii: [ot 6 dekabria 2021 g. №1122n (zareg. v Miniuste Rossii 20 dekabria 2021 g. №66435]. Available at: https://normativ.kontur.ru/document?moduleId=1&documentId=475217&ysclid=mang9jrahl951597019. Accessed: 09.04.2025 (in Russian)].

________________________________________________

1. Pul'monologiia. Natsional'noe rukovodstvo. Kratkoe izdanie. Pod red. A.G. Chuchalina. Moscow: GEOTAR-Media, 2013 (in Russian).
2. Bartlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis. 2000;31(2):347-82. DOI:10.1086/313954
3. Wenzel RP, Fowler AA. Acute Bronchitis. N Engl J Med. 2006;355(20):2125-10. DOI:10.1056/nejmcp061493
4. Albert RH. Diagnosis and treatment of acute bronchitis. Am Fam Physician. 2010;82(11):1345-50.
5. Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections – full version. Clin Microbiol Infect. 2011;(17 Suppl. 6):E1-59. DOI:10.1111/j.1469-0691.2011.03672.x
6. Zaitsev AA, Kulagina ITs. Acute bronchitis. Pharmacate. 2015;14(307):89-95 (in Russian).
7. Falsey AR, Criddle MM, Kolassa JE, et al. Evaluation of a handwashing intervention to reduce respiratory illness rates in senior day-care centers. Infect Control Hosp Epidemiol. 1999;20(3):200-2. DOI:10.1086/501612
8. Wark P. Bronchitis (acute). BMJ Clin Evid. 2015;2015:1508.
9. Macfarlane J, Holmes W, Gard P, et al. Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community. Thorax. 2001;56(2):109-14. DOI:10.1136/thorax.56.2.109
10. Smucny J, Fahey T, Becker L, Glazier R. Antibiotics for acute bronchitis. Cochrane Database Syst Rev. 2004;(4):CD000245. DOI:10.1002/14651858.CD000245.pub2
11. Gonzales R, Bartlett JG, Besser RE, et al. Principles of Appropriate Antibiotic Use for Treatment of Uncomplicated Acute Bronchitis: Background. Ann Intern Med. 2013;134(6):521-2. DOI:10.7326/0003-4819-134-6-200103200-00021
12. Irwin RS, Baumann MH, Bolser DC, et al. Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1 Suppl.):1S-23S. DOI:10.1378/chest.129.1_suppl.1S
13. Tackett KL, Atkins A. Evidence-based acute bronchitis therapy. J Pharm Pract. 2012;25(6):586-90. DOI:10.1177/0897190012460826
14. Zaitsev AA. Napravleniia farmakoterapii i profilaktiki ostrykh respiratornykh virusnykh infektsii. RMZh. 2009;17(23):1525-9 (in Russian).
15. Ott SR, Rohde G, Lepper PM, et al. The impact of viruses in lower respiratory tract infections of the adult. Part II: acute bronchitis, acute exacerbated COPD, pneumonia, and influenza. Pneumologie. 2010;64(1):18-27 (in German). DOI:10.1055/s-0029-1215197
16. Zaitsev AA, Kazakov SP, Filon EA, et al. Etiologiia i effektivnaia farmakoterapiia ostrogo bronkhita. Lechashchii vrach. 2025;28(1):32-7 (in Russian).
17. Zaitsev AA, Budoragin IE, Isaeva EI, et al. Ostryi bronkhit: rasstavliaem prioritety. Antibiotiki i khimioterapiia. 2019;64:17-22 (in Russian).
18. Zaitsev AA, Filon EA, Storozheva YI. Acute bronchitis – modern possibilities of mucactive therapy. Terapevticheskii Arkhiv (Ter. Arkh.). 2023;95(11):943-50 (in Russian). DOI:10.26442/00403660.2023.11.202470
19. Hart AM. Evidence-based diagnosis and management of acute bronchitis. Nurse Pract. 2014;39(9):32-9. DOI:10.1097/01.NPR.0000452978.99676.2b
20. Leshchenko IV, Zaitsev AA, Esaulova NA, Maliavin AG. Ostryi bronkhit. Osnovnye aktsenty. Terapiia. 2023;7:194-200 (in Russian).
21. Creer DD, Dilworth JP, Gillespie SH, et al. Aetiological role of viral and bacterial infections in acute adult lower respiratory tract infection (LRTI) in primary care. Thorax. 2006;61(1):75-9. DOI:10.1136/thx.2004.027441
22. Wadowsky RM, Castilla EA, Laus S, et al. Evaluation of Chlamydia pneumoniae and Mycoplasma pneumoniae as etiologic agents of persistent cough in adolescents and adults. J Clin Microbiol. 2002;40(2):637-40. DOI:10.1128/JCM.40.2.637-640.2002
23. Riffelmann M, Littmann M, Hülße C, et al. Pertussis bei Erwachsenen: Häufigkeit, Symptome und Kosten. Dtsch med Wochenschr. 2006;131(50):2829-84. DOI:10.1055/s-2006-957208
24. Leshchenko IV. Ostryi bronkhit. Moscow: GEOTAR-Media, 2019 (in Russian).
25. Zaytsev AA, Miroshnichenko NA, Ovchinnikov AY, Nikolaeva YO. Acute respiratory viral infections: Consensus on rational therapy. Consilium Medicum. 2024;26(9):575-7 (in Russian). DOI:10.26442/20751753.2024.9.202956
26. Knutson D, Braun C. Diagnosis and management of acute bronchitis. Am Fam Physician. 2002;65(10):2039-44.
27. Meza RA, Bridges-Webb C, Sayer GP, et al. The management of acute bronchitis in general practice: results from the Australian Morbidity and Treatment Survey, 1990–1991. Aust Fam Physician. 1994;23(8):1550-3.
28. Nennig ME, Shinefield HR, Edwards KM, et al. Prevalence and incidence of adult pertussis in an urban population. JAMA. 1996;275(21):1672-4.
29. Zaitsev AA, Ovchinnikov IuV, Kondrat'eva TV. Biologicheskie markery vospaleniia pri vnebol'nichnoi pnevmonii. Consilium Medicum. 2014;11:36-41 (in Russian).
30. Franck AJ, Smith RE. Antibiotic use for acute upper respiratory tract infections in a veteran population. J Am Pharm Assoc (2003). 2010;50(6):726-9. DOI:10.1331/JAPhA.2010.09103
31. Zaitsev AA, Kulagina ITs. Farmakoterapiia ostrogo bronkhita. Consilium Medicum. 2012;11(14):16-21 (in Russian).
32. Llor C, Moragas A, Bayona C, et al. Effectiveness of anti-inflammatory treatment versus antibiotic therapy and placebo for patients with non-complicated acute bronchitis with purulent sputum. The BAAP Study protocol. BMC Pulm Med. 2011;11:38. DOI:10.1186/1471-2466-11-38
33. Smith SM, Fahey T, Smucny J, Becker LA. Antibiotics for acute bronchitis. Cochrane Database Syst Rev. 2017;6(6):CD000245. DOI:10.1002/14651858.CD000245.pub4
34. Mainous AG 3rd, Saxena S, Hueston WJ, et al. Ambulatory antibiotic prescribing for acute bronchitis and cough and hospital admissions for respiratory infections: time trends analysis. J R Soc Med. 2006;99(7):358-62. DOI:10.1177/014107680609900719
35. Strategiia i taktika ratsional'nogo primeneniia antimikrobnykh sredstv v ambulatornoi praktike: evraziiskie klinicheskie rekomendatsii. Moscow: MedKom-Pro, 2022 (in Russian).
36. Respiratory tract infections (self-limiting): prescribing antibiotics. Available at: http://www.nice.org.uk/CG069. Accessed: 09.04.2025.
37. Altiner A, Wilm S, Däubener W, et al. Sputum colour for diagnosis of a bacterial infection in patients with acute cough. Scand J Prim Health Care. 2009;27(2):70-3. DOI:10.1080/02813430902759663
38. Laopaiboon M, Panpanich R, Swa Mya K. Azithromycin for acute lower respiratory tract infections. Cochrane Database Syst Rev. 2015;2015(3):CD001954. DOI:10.1002/14651858.CD001954.pub4
39. Profilaktika, diagnostika i lechenie novoi koronavirusnoi infektsii COVID-19. Vremennye metodicheskie rekomendatsii. Versiia 18. 26.10.2023 (in Russian).
40. Smucny J, Flynn C, Becker L, Glazier R. Beta2-agonists for acute bronchitis. Cochrane Database Syst Rev. 2004;(1):CD001726. DOI:10.1002/14651858.CD001726.pub2
41. El-Gohary M, Hay AD, Coventry P, et al. Corticosteroids for acute and subacute cough following respiratory tract infection: a systematic review. Fam Pract. 2013;30(5):492-500. DOI:10.1093/fampra/cmt034
42. Zaitsev AA, Okovityi SV, Kriukov EV. Kashel'. Prakticheskoe posobie dlia vrachei. Moscow. 2015 (in Russian).
43. Kupaev VI. Otsenka effektivnosti terapii ostrogo bronkhita kombinatsiei mukolitika/b2-agonista po sravneniiu s monoterapiei mukolitikom v real'noi obshchei vrachebnoi praktike. Doktor.ru. 2017;5:16-18 (in Russian).
44. Prabhu Shankar S, Chandrashekharan S, Bolmall CS, Baliga V. Efficacy, safety and tolerability of salbutamol + guaiphenesin + bromhexine (Ascoril) expectorant versus expectorants containing salbutamol and either guaiphenesin or bromhexine in productive cough: a randomised controlled comparative study. J Indian Med Assoc. 2010;108(5):313-4, 316-8, 320.
45. Kemmerich B. Evaluation of efficacy and tolerability of a fixed combination of dry extracts of thyme herb and primrose root in adults suffering from acute bronchitis with productive cough. A prospective, double-blind, placebo-controlled multicentre clinical trial. Arzneimittelforschung. 2007;57(9):607-15. DOI:10.1055/s-0031-1296656
46. Kemmerich B, Eberhardt R, Stammer H. Efficacy and tolerability of a fluid extract combination of thyme herb and ivy leaves and matched placebo in adults suffering from acute bronchitis with productive cough. A prospective, double-blind, placebo-controlled clinical trial. Arzneimittelforschung. 2006;56(9):652-60. DOI:10.1055/s-0031-1296767
47. Zaitsev  AA, Leshchenko IV, Esaulova NA, Viktorova IA. Evaluation of the efficacy and safety of a combination drug containing ambroxol, guaifenesin, and levosalbutamol versus a fixed-dose combination of bromhexine/guaifenesin/salbutamol in the treatment of productive cough in adult patients with acute bronchitis. Terapevticheskii Arkhiv (Ter. Arkh.). 2023;95(3):236-42 (in Russian). DOI:10.17116/profmed202326061108
48. Leshchenko IV, Esaulova NA. Combination therapy for productive cough in acute respiratory viral infection (ARVI) and acute bronchitis in real clinical practice. Terapevticheskii Arkhiv (Ter. Arkh.). 2024;96(1):46-52 (in Russian). DOI:10.26442/00403660.2024.01.202584
49. Zaitsev AA, Kulikova NA, Filon EA, et al. Clinical efficacy of mucoactive therapy with 7% hypertonic saline in patients with acute bronchitis. Meditsinskiy sovet = Medical Council. 2023;(23):136-41 (in Russian). DOI:10.21518/2079-701x-2022-16-23-136-141
50. Vibroakusticheskaia terapiia. Klinicheskii protokol. Available at: https://amu.edu.kz/ru/personal/Clinical-work/clinic/Clinical-protocols. Accessed: 09.04.2025 (in Russian).
51. Ob utverzhdenii natsional'nogo kalendaria profilakticheskikh privivok, kalendaria profilakticheskikh privivok po epidemicheskim pokazaniiam i poriadka provedeniia profilakticheskikh privivok: prikaz Minzdrava Rossii: [ot 6 dekabria 2021 g. №1122n (zareg. v Miniuste Rossii 20 dekabria 2021 g. №66435]. Available at: https://normativ.kontur.ru/document?moduleId=1&documentId=475217&ysclid=mang9jrahl951597019. Accessed: 09.04.2025 (in Russian).

С.Н. Авдеев^1,2, А.А. Зайцев*^3–5, И.В. Лещенко^6,7, от имени рабочей группы по разработке и пересмотру Федеральных клинических рекомендаций по острому бронхиту

¹ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет), Москва, Россия;
²ФГБУ «Научно-исследовательский институт пульмонологии» ФМБА России, Москва, Россия;
³ФГБУ «Главный военный клинический госпиталь им. акад. Н.Н. Бурденко» Минобороны России, Москва, Россия;
⁴ФГБОУ ВО «Российский биотехнологический университет (РОСБИОТЕХ)», Москва, Россия;
⁵ФГБОУ ВО «Российский университет медицины», Москва, Россия;
⁶ФГБОУ ВО «Уральский государственный медицинский университет» Минздрава России, Екатеринбург, Россия;
⁷Уральский научно-исследовательский институт фтизиопульмонологии – филиал ФГБУ «Национальный медицинский исследовательский центр фтизиопульмонологии и инфекционных заболеваний», Екатеринбург, Россия
*a-zaicev-a@yandex.ru

________________________________________________

Sergey N. Avdeev^1,2, Andrey A. Zaytsev*^3–5, Igor V. Leshchenko^6,7, on behalf of the working group for the development and revision of Federal clinical guidelines for acute bronchitis

¹Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia;
²Research Institute of Pulmonology, Moscow, Russia;
³Burdenko Main Military Clinical Hospital, Moscow, Russia;
⁴Russian Biotechnological University, Moscow, Russia;
⁵Russian University of Medicine, Moscow, Russia;
⁶Ural State Medical University, Yekaterinburg, Russia;
⁷Ural Research Institute of Phthisiopulmonology – branch of the National Medical Research Center for Phthisiopulmonology and Infectious Diseases, Yekaterinburg, Russia
*a-zaicev-a@yandex.ru